about
Phosphorylation-dependent regulation of stability and transforming potential of ETS transcriptional factor ESE-1 by p21-activated kinase 1Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysisLandscape of genomic alterations in cervical carcinomas.Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypes.The ETS transcription factor ESE-1 transforms MCF-12A human mammary epithelial cells via a novel cytoplasmic mechanism.Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells.The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesisExpression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation.Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors.miR-124 Regulates the Epithelial-Restricted with Serine Box/Epidermal Growth Factor Receptor Signaling Axis in Head and Neck Squamous Cell Carcinoma.Genetic and chemical targeting of epithelial-restricted with serine box reduces EGF receptor and potentiates the efficacy of afatinib.Multiple roles of the epithelium-specific ETS transcription factor, ESE-1, in development and disease.Different domains of the transcription factor ELF3 are required in a promoter-specific manner and multiple domains control its binding to DNA.Genome position and gene amplificationESE-1/ELF3 mRNA expression associates with poor survival outcomes in HER2+ breast cancer patients and is critical for tumorigenesis in HER2+ breast cancer cells.Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma.ESE-1 Knockdown Attenuates Growth in Trastuzumab-resistant HER2+ Breast Cancer Cells.Prostatic intraepithelial neoplasia and adenocarcinoma in mice expressing a probasin-Neu oncogenic transgene.ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and Cancer
P2860
Q28301467-B5CF3C55-F3DA-4EBD-B511-0AC6BCCC1B82Q28749779-A105434C-6C07-40D1-998E-4F78649E5F16Q34169464-1026E36D-91DE-431B-85B8-B0E88AC56D2BQ34323234-71723848-9467-46C3-B3D3-AD87A67F8AE1Q34347627-78A30DE2-8B02-4BEE-B98A-455690171897Q34415831-7E263762-270B-4844-AE47-34ECD0BAD2CAQ34493341-2E7705BE-45F8-4556-A416-C2638C0A0F3CQ35747809-60F81F04-5D38-4622-81F3-20DDFB490977Q35926362-F556CF9E-1958-45BA-A31C-2C4FB4DD897DQ36132797-EBB0BD70-F3B5-4FC5-8286-441FCE1BD523Q37101367-8142870A-4146-477E-92A7-3397741E4D70Q37967013-8B422835-8463-460A-85D8-E086D59B5134Q38306980-27884F51-2760-4DDF-9079-ACE29FFEEFFCQ38606305-B6E843D4-353B-4720-AFEC-EE17FD826663Q42378364-0786D544-D127-4FCC-AF70-B80C738386A7Q46433336-A0D61BAA-3D8B-4005-8199-2270B44DACF0Q47350657-E4D1F84E-3CF5-4CC1-9226-5ABC4DEC4280Q53350536-FC7BD094-6805-4611-9603-75CEA07CF43AQ58696663-3BDB5E96-85DC-4686-8448-CA80B7708916
P2860
description
article
@en
im Mai 2002 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2002
@uk
ലേഖനം
@ml
name
ErbB2 Activation of ESX gene expression
@en
ErbB2 Activation of ESX gene expression
@nl
type
label
ErbB2 Activation of ESX gene expression
@en
ErbB2 Activation of ESX gene expression
@nl
prefLabel
ErbB2 Activation of ESX gene expression
@en
ErbB2 Activation of ESX gene expression
@nl
P2093
P2860
P356
P1433
P1476
ErbB2 Activation of ESX gene expression
@en
P2093
Christopher C Benz
Chuan-Hsiung Chang
Donna G Albertson
Richard M Neve
P2860
P2888
P304
P356
10.1038/SJ.ONC.1205503
P407
P50
P577
2002-05-01T00:00:00Z